MAVATAR Trademark

Pharmaceutical preparations, namely, medical diagnostic reagents for identifying treatment response in oncology and inflammatory diseases; diagnostic biomarker reagents for medical purposes.

Provision of access to databases; Provision of access to databases containing biomedical data.

Compiling of biomedical data into computer databases for business purposes; providing online business organization workflow information to pharmaceutical companies to enable streamlining of drug discovery and development.

Research and development services in the field of medical preparations; Medical and scientific research and development services in the fields of precision medicine and pharmaceutical drug development; biomedical research services; Platform as a service (PAAS) featuring computer software using artificial intelligence (AI) for integrating model data with biomedical data of patients to create a digital twin of a patient; Software as a service (SAAS) services featuring software for integrating model data with biomedical data of a patient to create a digital twin of a patient; Platform as a service (PAAS) featuring computer software using artificial intelligence (AI) for integrating model data with biomedical data to create a digital twin of a patient; Software as a service (SAAS) services featuring software for integrating model data with biomedical data to create a digital twin of a patient; Platform as a service (PAAS) featuring computer software using artificial intelligence (AI) for research and analysis of medical and biomedical data; Software as a service (SAAS) services featuring software for research and analysis of medical and biomedical data; Platform as a service (PAAS) featuring computer software using artificial intelligence (AI) for gathering, compiling, analyzing, authenticating, validating, controlling, protecting, exchanging, and modifying genetic, genomic, molecular and biomarker data; Software as a service (SAAS) services featuring software for gathering, compiling, analyzing, authenticating, validating, controlling, protecting, exchanging and modifying genetic, genomic, molecular and biomarker data; Platform as a service (PAAS) featuring computer software using artificial intelligence (AI) for comparing patient biomarker data against genetic, proteomic, and transcriptomic database; Software as a service (SAAS) services featuring software for comparing patient biomarker data against genetic, proteomic, and transcriptomic database; Platform as a service (PAAS) featuring computer software using artificial intelligence (AI) for the collection, editing, organizing, modifying, transmission, storage, and sharing of data and information for use by pharmaceutical companies and healthcare providers; Software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, transmission, storage, and sharing of data and information for use by pharmaceutical companies and healthcare providers; Platform as a service (PAAS) featuring computer software using artificial intelligence (AI) for developing drugs by simulating patient responses to medications; Software as a service (SAAS) services featuring software for developing drugs by simulating patient responses to medications; Platform as a service (PAAS) featuring computer software using artificial intelligence (AI) for predicting patient treatment response; Software as a service (SAAS) services featuring software for predicting patient treatment response; providing medical and scientific research information; information services relating to pharmaceutical drug development; information services provided via the internet, namely providing information to pharmaceutical companies to streamline drug discovery and development; providing online pharmaceutical drug research information via the internet to pharmaceutical companies to enable streamlining of drug discovery and development; providing scientific analysis related to genetic, genomic, molecular, and biomarker data; software as a service (SAAS) services featuring software that enables users to access, track, monitor and generate informational reports based upon results of genetic, genomic, molecular, and biomarker data.

Downloadable software for medical diagnostics; downloadable databases in the fields of medical information, medical research, medical diagnostics and medical treatments; Downloadable artificial intelligence software that integrates model data with biomedical data of patients to create a digital twin of a patient; Downloadable artificial intelligence software that integrates model data with biomedical data to create a digital twin of a patient; Downloadable software for research and analysis of medical and biomedical data; Downloadable software for gathering, compiling, analyzing, authenticating, validating, controlling, protecting, exchanging, and modifying genetic, genomic, molecular, and biomarker data; Downloadable software for comparing patient biomarker data against genetic, proteomic, and transcriptomic database; Downloadable software for the collection, editing, organizing, modifying, transmission, storage, and sharing of data and information for use by pharmaceutical companies and healthcare providers; Downloadable software for developing drugs by simulating patient responses to medications; Downloadable software for predicting patient treatment response; downloadable databases containing biomedical data.

Healthcare information services; healthcare consultancy services; healthcare services; Medical information services provided via the Internet, namely providing personalized treatment suggestions to medical professionals tailored after their patients' health profile; Medical information services provided via the Internet, namely providing medical information to pharmaceutical companies to streamline drug discovery and development; Provision of medical information from online databases.